Cryo Cell International (CCEL) Total Current Liabilities (2010 - 2026)

Cryo Cell International (CCEL) has 17 years of Total Current Liabilities data on file, last reported at $17.8 million in Q1 2026.

• Quarterly Total Current Liabilities fell 18.22% year-over-year to $17.8 million in Q1 2026, while the trailing twelve-month figure through Feb 2026 was $17.8 million (down 18.22% YoY) and the FY2025 annual result came in at $19.8 million, down 8.36% from the prior year.
• Total Current Liabilities fell to $17.8 million in Q1 2026 per CCEL's latest filing, from $19.8 million in the prior quarter.
• Across five years, Total Current Liabilities topped out at $23.6 million in Q3 2022 and bottomed at $15.7 million in Q2 2022.
• The 5-year median for Total Current Liabilities is $19.4 million (2024), against an average of $19.4 million.
• The widest annual swing landed in 2022, when Total Current Liabilities slumped 45.09%; it then advanced 25.44% in 2023.
• Tracing CCEL's Total Current Liabilities over 5 years: stood at $19.5 million in 2022, then increased by 7.1% to $20.9 million in 2023, then gained by 3.53% to $21.6 million in 2024, then decreased by 8.36% to $19.8 million in 2025, then slipped by 10.25% to $17.8 million in 2026.
• Per Business Quant, the three latest CCEL Total Current Liabilities figures stand at $17.8 million (Q1 2026), $19.8 million (Q4 2025), and $18.5 million (Q3 2025).

Peer Comparison